FDA MedWatch

Nationwide recall due to complaints about stretching or fracture
of the sheath during use.

Nationwide recall of all lots of product due to potential for needle to become detached from syringe during use.

Investigational antiviral drug approved for emergency use in H1N1 influenza infection; mandatory reporting of adverse events required by healthcare providers.

Third case of PML reported, the first case of PML in a patient with rheumatoid arthritis treated with Rituxan who has not previously received treatment with a TNF antagonist.

Nationwide recall due to the potential for particulate matter in conjunction with crystallization in the product.

Reports of sparking, charring, and fires from device power cords.

Risk of anaphylactic-type reactions, including fatalities, have followed the parenteral administration of iron dextran injection.

Drug must not be reconstituted in liquid formulation or used in any nebulizer or mechanical ventilator.

Initial Notification of risk of radiation overexposures during CT brain perfusion scans.

Recall due to malfunction which impairs ability of device to generate positive pressure necessary to function properly.